相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort
Arka De et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)
Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
Lorenzo A. Orci et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease
Ajay Duseja et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2022)
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double-Blind Phase 2 Trial
Manas Kumar Panigrahi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)
Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population
Mohammad S. Kuchay et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)
NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver
Arka De et al.
JOURNAL OF HEPATOLOGY (2022)
Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis
Fateh Bazerbachi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review
Heather Patton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map
Jai Kumar et al.
DIGESTIVE AND LIVER DISEASE (2021)
Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty
Kaveh Hajifathalian et al.
GASTROINTESTINAL ENDOSCOPY (2021)
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani et al.
GUT (2021)
Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India
Harpreet Grewal et al.
TROPICAL DOCTOR (2021)
Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors
Narendra S. Choudhary et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease
Andreas Vadarlis et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review
Jenny Lee et al.
LIVER INTERNATIONAL (2021)
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure
Ajay Duseja et al.
LIVER INTERNATIONAL (2021)
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
Zobair M. Younossi et al.
GASTROENTEROLOGY (2021)
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
Jinho Jung et al.
GUT (2021)
FibroScan-aspartate aminotransferase score in an Asian cohort of non-alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery
Abhinav Anand et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
Shivaram Prasad Singh et al.
JOURNAL OF HEPATOLOGY (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
CAP for the detection of hepatic steatosis in clinical practice
Giovanna Ferraioli
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
David Petroff et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery
Shirley Yuk-Wah Liu et al.
SCIENTIFIC REPORTS (2021)
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
Emmanuel Anandraj Selvaraj et al.
JOURNAL OF HEPATOLOGY (2021)
Intermittent Fasting and Obesity-Related Health Outcomes An Umbrella Review of Meta-analyses of Randomized Clinical Trials
Chanthawat Patikorn et al.
JAMA NETWORK OPEN (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis
Hidekatsu Kuroda et al.
PLOS ONE (2021)
Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis
Suneel Tohra et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)
Anti-diabetic drugs and NASH: from current options to promising perspectives
Sarra Smati et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
Annalisa Berzigotti et al.
JOURNAL OF HEPATOLOGY (2021)
New drugs for NASH
Somaya A. M. Albhaisi et al.
LIVER INTERNATIONAL (2021)
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
Samer Gawrieh et al.
HEPATOLOGY (2021)
Comparison of Elastography Point Quantification with Transient Elastography in Patients with Chronic Viral Hepatitis and Nonalcoholic Fatty Liver Disease: A Pilot Study
Savinay Kapur et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver
Pankaj Puri et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)
Changing Nomenclature from Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Fatty Liver Disease - Not Only Premature But Also Confusing
Ajay Duseja et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Sabine Kahl et al.
DIABETES CARE (2020)
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures-2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Jeffrey I. Mechanick et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2020)
Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis
Eduardo Vilar-Gomez et al.
HEPATOLOGY (2020)
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2020)
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Robert Ross et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
OSSI (Obesity and Metabolic Surgery Society of India) Guidelines for Patient and Procedure Selection for Bariatric and Metabolic Surgery
A. G. Bhasker et al.
OBESITY SURGERY (2020)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease
Samir Shah et al.
JOURNAL OF HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice
Stavra A. Xanthakos et al.
GASTROENTEROLOGY (2020)
Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis
Feng-Bin Lu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison et al.
JOURNAL OF HEPATOLOGY (2020)
Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
Omesh Goyal et al.
SCIENTIFIC REPORTS (2020)
Prevalence of fatty liver in metabolic syndrome
Anita Goyal et al.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2020)
The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
Mohamed Abdel-Maboud et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Nonalcoholic steatohepatitis recurrence after liver transplant
Sunil Taneja et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis
Steven Young et al.
HEPATOLOGY COMMUNICATIONS (2020)
Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients
Jimmy Narayan et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2020)
Natural History of Simple Steatosis or Nonalcoholic Fatty Liver
Arka De et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity
Mathew Vadukoot Lazar et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2020)
Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index
Nikhil Makhija et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!
Mayank Jain et al.
JGH OPEN (2020)
Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review
Raseen Tariq et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
Semanti Chakraborty et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease
Shalimar et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2020)
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity
Nirmalya Sinha et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2020)
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
Mohammad S. Siddiqui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants
Cynthia Hsu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians
Surya Prakash Bhatt et al.
SLEEP AND BREATHING (2019)
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
JOURNAL OF HEPATOLOGY (2019)
Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications
A. J. Scheen
DIABETES & METABOLISM (2019)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes et al.
GASTROENTEROLOGY (2019)
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
Ke Pu et al.
BMC GASTROENTEROLOGY (2019)
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study
Debashis Haldar et al.
JOURNAL OF HEPATOLOGY (2019)
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
Ankur Srivastava et al.
JOURNAL OF HEPATOLOGY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
Jane Chalmers et al.
BMJ OPEN (2019)
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Eduardo Vilar-Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
New dual peroxisome proliferator activated receptor agonistSaroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence
Upendra Kaul et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee et al.
HEPATOLOGY (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
Paul J. Pockros et al.
LIVER INTERNATIONAL (2019)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Yung Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
Rohit Loomba et al.
GASTROENTEROLOGY (2019)
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
GUT (2019)
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib
Saumya Jayakumar et al.
JOURNAL OF HEPATOLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis
Zita Galvin et al.
LIVER TRANSPLANTATION (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
Giacomo Germani et al.
TRANSPLANTATION (2019)
Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?
Narendra S. Choudhary et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients
Gyanranjan Rout et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease
Ram V. Nampoothiri et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
Kailash Marotrao Kolhe et al.
BMJ OPEN GASTROENTEROLOGY (2019)
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi et al.
JHEP REPORTS (2019)
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern
Ekta Dhamija et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India
Ajay Duseja et al.
JGH OPEN (2019)
Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease
Narendra S. Choudhary et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Association of Normal-Weight Central Obesity With All-Cause and Cause-Specific Mortality Among Postmenopausal Women
Yangbo Sun et al.
JAMA NETWORK OPEN (2019)
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
Annieke C. G. van Baar et al.
JHEP REPORTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 2: Management and special groups
Shiv Chitturi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Early major complications after bariatric surgery in the USA, 2003-2014: a systematic review and meta-analysis
S. -H. Chang et al.
OBESITY REVIEWS (2018)
An Overview of Liver Transplant Pathology: Data from a Tertiary Referral Centre in Western India
Fiona Fonseca et al.
ANNALS OF HEPATOLOGY (2018)
The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom
Nadege T. Gunn et al.
CLINICS IN LIVER DISEASE (2018)
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
Mohammad Shafi Kuchay et al.
DIABETES CARE (2018)
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials
Cyrielle Caussy et al.
HEPATOLOGY (2018)
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M. Younossi et al.
HEPATOLOGY (2018)
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise
Vincent Wai-Sun Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients
Harshit Garg et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOMEA (R) trial
Naveed Sattar et al.
DIABETOLOGIA (2018)
Liver Transplantation and Bariatric Surgery: Timing and Outcomes
Tayyab S. Diwan et al.
LIVER TRANSPLANTATION (2018)
SAF score and mortality in NAFLD after up to 41 years of follow-up
Hannes Hagstrom et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Charlie C. Park et al.
GASTROENTEROLOGY (2017)
Exercise and NAFLD: Is It Worth the Effort?
George G. Schweitzer et al.
HEPATOLOGY (2017)
Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis
Matthew J. Klebanoff et al.
HEPATOLOGY (2017)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Non-invasive evaluation of portal hypertension using ultrasound elastography
Annalisa Berzigotti
JOURNAL OF HEPATOLOGY (2017)
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas et al.
JOURNAL OF HEPATOLOGY (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
Ryuki Hashida et al.
JOURNAL OF HEPATOLOGY (2017)
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)
Miriam B. Vos et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil
Delia D'Avola et al.
LIVER TRANSPLANTATION (2017)
Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history
L. D. Clamp et al.
NUTRITION & DIABETES (2017)
Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?
Manu Mehta et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2017)
Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India
Deepu David et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2017)
Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis
Adnan Said et al.
ANNALS OF HEPATOLOGY (2017)
Liver Transplantation and Bariatric Surgery Best Approach
Duminda Suraweera et al.
CLINICS IN LIVER DISEASE (2017)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
David E. Kleiner et al.
CLINICS IN LIVER DISEASE (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study
Wenjing Sun et al.
HEPATOLOGY RESEARCH (2016)
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease
Victor de Ledinghen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation
Sandra Carias et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver
Ki-Chul Sung et al.
JOURNAL OF HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Critical comparison of elastography methods to assess chronic liver disease
Mireen Friedrich-Rust et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Chronic hepatitis B and fatty liver: Issues in clinical management
Rajneesh Kumar et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Intragastric balloon as a novel modality for weight loss in patients with cirrhosis and morbid obesity awaiting liver transplantation
Narendra Singh Choudhary et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2016)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center
Swastik Agrawal et al.
HEPATOLOGY INTERNATIONAL (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
Liver Biopsy in Children: Position Paper of the ESPGHAN Hepatology Committee
Antal Dezsofi et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis
Ahmad Jan et al.
OBESITY SURGERY (2015)
Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?
Shivaram Prasad Singh et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
Lisa M. Glass et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohort
M. Srinivas et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2015)
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology
Ajay Duseja et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2015)
Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding
Laura Folini et al.
ACTA DIABETOLOGICA (2014)
Comparison of Characteristics Between Nonobese and Overweight/Obese Subjects with Nonalcoholic Fatty Liver Disease in a South Indian Population
Ramanujam Vendhan et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Effect of a 6-Month Intervention with Cooking Oils Containing a High Concentration of Monounsaturated Fatty Acids (Olive and Canola Oils) Compared with Control Oil in Male Asian Indians with Nonalcoholic Fatty Liver Disease
Priyanka Nigam et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease
Wah-Kheong Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Recurrent or De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation: Natural History Based on Liver Biopsy Analysis
Melanie Vallin et al.
LIVER TRANSPLANTATION (2014)
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen
Amedeo Lonardo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshio Sumida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
Ebenezer T. Oni et al.
ATHEROSCLEROSIS (2013)
Liver Stiffness Measurements in Patients with Different Stages of Nonalcoholic Fatty Liver Disease: Diagnostic Performance and Clinicopathological Correlation
Ramesh Kumar et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Hedgehog Pathway and Pediatric Nonalcoholic Fatty Liver Disease
Marzena Swiderska-Syn et al.
HEPATOLOGY (2013)
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
David van der Poorten et al.
HEPATOLOGY (2013)
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
Marno C. Ryan et al.
JOURNAL OF HEPATOLOGY (2013)
Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India
Priyanka Nigam et al.
PLOS ONE (2013)
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
Vincent Wai-Sun Wong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants
Nabeen C. Nayak et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Yin-Mei Lee et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
Pierre Bedossa et al.
HEPATOLOGY (2012)
The TONIC trial: A step forward in treating pediatric nonalcoholic fatty liver disease
Naim Alkhouri et al.
HEPATOLOGY (2012)
Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Shelley E. Keating et al.
JOURNAL OF HEPATOLOGY (2012)
Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee
Pietro Vajro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
Victor de Ledinghen et al.
LIVER INTERNATIONAL (2012)
Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
Mattias Ekstedt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease
Ganesh Bhat et al.
WORLD JOURNAL OF HEPATOLOGY (2012)
Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD)
Narendra S. Choudhary et al.
ANNALS OF HEPATOLOGY (2012)
Validation of the non-alcoholic fatty liver disease activity score
M. Hjelkrem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Increased Perioperative Mortality Following Bariatric Surgery Among Patients With Cirrhosis
Jeffrey D. Mosko et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease
Gabriela Ruffillo et al.
JOURNAL OF HEPATOLOGY (2011)
Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients
Rosario Forlano et al.
GASTROINTESTINAL ENDOSCOPY (2010)
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
Vincent Wai-Sun Wong et al.
GUT (2010)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease
Vincent Wai-Sun Wong et al.
HEPATOLOGY (2010)
Nonalcoholic Fatty Liver in a Developing Country is Responsible for Significant Liver Disease
Ajay Duseja et al.
HEPATOLOGY (2010)
Nonobese Population in a Developing Country Has a High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease
Kausik Das et al.
HEPATOLOGY (2010)
End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program
Nabeen C. Nayak et al.
HUMAN PATHOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
The clinicopathological profile of indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the west
Ajay Duseja et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Prevalence of non-alcoholic fatty liver disease: population based study
Deepak Amarapurkar et al.
ANNALS OF HEPATOLOGY (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians
Kaushal Madan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis
CS Baba et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Review article: non-alcoholic fatty liver disease and hepatitis C - risk factors and clinical implications
AJ Sanyal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Macrovesicular hepatic steatosis in living related liver donors: Correlation between CT and histologic findings
P Limanond et al.
RADIOLOGY (2004)
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
P Mofrad et al.
HEPATOLOGY (2003)
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh et al.
GASTROENTEROLOGY (2002)
Current concepts: Liver biopsy.
AA Bravo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)